Phase III Randomized Trial of Patient-Specific Vaccination for Previously Untreated Patients with Follicular Lymphoma in First Complete Remission: Protocol Summary and Interim Report-Reference-Cited by-同舟云学术

Phase III Randomized Trial of Patient-Specific Vaccination for Previously Untreated Patients with Follicular Lymphoma in First Complete Remission: Protocol Summary and Interim Report

Published:2005-06 Issue:1 Volume:6 Page:61-64
ISSN:1526-9655
Container-title:Clinical Lymphoma
language:en
Short-container-title:Clinical Lymphoma

Author:

Neelapu Sattva S.,Gause Barry L.,Nikcevich Daniel A.,Schuster Stephen J.,Winter Jane,Gockerman Jon P.,Loughran Thomas,Takeshita Ken,Inghirami Giorgio,McGaughey Dean,Watson Thelma M.,Snow Sandra,Kubovic Paula,Ferraro Miriam,Jones Elizabeth,Jaffe Elaine S.,Schwartzentruber Douglas J.,Danforth David,Sherry Richard,Kass Erik,Van Waes Carter,Reynolds Craig W.,Kwak Larry W.

Publisher

Elsevier BV

Subject

Cancer Research

Reference21 articles.

1. Current treatment of follicular low-grade lymphomas;Peterson;Semin Oncol,1999

2. Autoimmune-like antibodies to the ligand-binding sites of myeloma proteins;Sirisinha;Proc Natl Acad Sci U S A,1971

3. Myeloma proteins as tumor-specific transplantation antigens;Lynch;Proc Natl Acad Sci U S A,1972

4. Protective and cellular immune responses to idiotypic determinants on cells from a spontaneous lymphoma of NZB/NZWF1 mice;Sugai;J Exp Med,1974

5. Antibody to molecularly defined antigen confined to a tumor cell surface;Stevenson;Nature,1975

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Vaccines for Follicular Lymphoma: A Systematic Review;Pharmaceuticals;2024-02-21

2. B-cell lymphomas present immunoglobulin neoantigens;Blood;2019-02-21

3. Combination immunotherapy and radiation therapy strategies for pancreatic cancer—targeting multiple steps in the cancer immunity cycle;Journal of Gastrointestinal Oncology;2018-12

4. Cellular immunotherapy of cancer: an overview and future directions;Immunotherapy;2017-06

5. The role of novel immunotherapies in non-Hodgkin lymphoma;Translational Cancer Research;2017-02